Global Molecular Information Systems Market
Global Molecular Information Systems Market

Molecular Information Systems Comprehensive Study by Type (Reagents & Kits, Software & Service, Instruments (Table-top Instruments, Portable & PoC Instruments)), Application (Oncology, Infectious Disease (COVID-19, Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other), Genetic Tests, Oncology Testing (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other), Others), Technology (Polymerase Chain Reaction (PCR), DNA Sequencing & NSS, DNA Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), End User (Hospital & Academic Laboratories, Clinics, Diagnostic Laboratories, Others) Players and Region - Global Market Outlook to 2026

Molecular Information Systems Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 233 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Molecular Information Systems Market Overview:
A molecular information system is often used to determine the sequence in DNA or genetic material, enzymes, proteins at the molecular level using kits, reagents, and instruments. Various methods are used to determine the sequence in molecular information, including the use of instruments such as PCR, RAPD, and DNA microarrays. Molecular information systems are beneficial in a variety of medical strengths including infectious diseases, oncology, human leukocyte antigens typing and coagulation, and pharmacogenomics. The impact of COVID-19 on digital solutions in terms of healthcare delivery has been and is very high and accelerating as fast as COVID-19 moves around the world. There are many lessons to be learned from the use of technology in public health monitoring, from linking data in Sentinel laboratories to developing technological solutions to instantly link tests in different geographic locations.

Growth Drivers
  • Increase in Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
  • High Prevalence of Infectious Diseases and Various Types of Cancers

Market Trends
  • Increasing Demand for Point-Of-Care Diagnostics

Roadblocks
  • Strict Regulatory and Legal Requirements Related To the System
  • Need For high-complexity Testing Centers

Opportunities
  • The Growing Advances in Genomics and Proteomics
  • Rising Usage of Well-Established Technologies, Such As Immunoassays

Challenges
  • Delay in Approval of New Molecular Information


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Biomerieux SA (France), Becton, Dickinson, and Company (United States), Danaher Corporation (United States), F.Hoffmann-La Roche (Switzerland), Hologic Inc. (United States), Siemens Healthineers AG (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (United States), DiaSorin S.p.A. (Italy) and Luminex Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like Molbio Diagnostics Pvt. Ltd. (India) and geneOmbio Technologies Pvt. Ltd. (India). Analyst at AMA Research see United States Players to retain maximum share of Global Molecular Information Systems market by 2026. Considering Market by Technology, the sub-segment i.e. Polymerase Chain Reaction (PCR) will boost the Molecular Information Systems market. Considering Market by End User, the sub-segment i.e. Hospital & Academic Laboratories will boost the Molecular Information Systems market.

Latest Market Insights:
In January 2021, Hologic Inc. had acquired Biotheranostics Inc. for expanding its molecular diagnostics portfolio. and In May 2020, Roche Diagnostics had acquired Stratos Genomics so as to complement the development of its nanopore technology and thereby gave access to Stratos Genomic's unique chemistry, Sequencing by Expansion (SBX).

In March 2020, Abbott Laboratories had launched the ID NOW PoC testing system.

The FDA has emphasized that it has regulatory authority over LDTs (laboratory-developed tests) but has chosen to exercise some enforcement discretion on such tests. In recent years, however, the FDA has stated that additional monitoring of LDTs is required and that the agency plans to issue a guidance document on it. Even issuing the draft directive will therefore certainly raise questions and create new problems.

What Can be Explored with the Molecular Information Systems Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Molecular Information Systems Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Molecular Information Systems
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Molecular Information Systems market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Molecular Information Systems market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Molecular Information Systems, Venture Capitalists and Private Equity Firms and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Reagents & Kits
  • Software & Service
  • Instruments [Table-top Instruments, Portable & PoC Instruments]
By Application
  • Oncology
  • Infectious Disease [COVID-19, Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other]
  • Genetic Tests
  • Oncology Testing [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other]
  • Others
By Technology
  • Polymerase Chain Reaction (PCR)
  • DNA Sequencing & NSS
  • DNA Microarrays
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

By End User
  • Hospital & Academic Laboratories
  • Clinics
  • Diagnostic Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
      • 3.2.2. High Prevalence of Infectious Diseases and Various Types of Cancers
    • 3.3. Market Challenges
      • 3.3.1. Delay in Approval of New Molecular Information
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Point-Of-Care Diagnostics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Information Systems, by Type, Application, Technology, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Molecular Information Systems (Value)
      • 5.2.1. Global Molecular Information Systems by: Type (Value)
        • 5.2.1.1. Reagents & Kits
        • 5.2.1.2. Software & Service
        • 5.2.1.3. Instruments [Table-top Instruments, Portable & PoC Instruments]
      • 5.2.2. Global Molecular Information Systems by: Application (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. Infectious Disease [COVID-19, Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other]
        • 5.2.2.3. Genetic Tests
        • 5.2.2.4. Oncology Testing [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other]
        • 5.2.2.5. Others
      • 5.2.3. Global Molecular Information Systems by: Technology (Value)
        • 5.2.3.1. Polymerase Chain Reaction (PCR)
        • 5.2.3.2. DNA Sequencing & NSS
        • 5.2.3.3. DNA Microarrays
        • 5.2.3.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        • 5.2.3.5. Others
      • 5.2.4. Global Molecular Information Systems by: End User (Value)
        • 5.2.4.1. Hospital & Academic Laboratories
        • 5.2.4.2. Clinics
        • 5.2.4.3. Diagnostic Laboratories
        • 5.2.4.4. Others
      • 5.2.5. Global Molecular Information Systems Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Molecular Information Systems (Price)
      • 5.3.1. Global Molecular Information Systems by: Type (Price)
  • 6. Molecular Information Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biomerieux SA (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson, and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. F.Hoffmann-La Roche (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hologic Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Siemens Healthineers AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. QIAGEN N.V. (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. DiaSorin S.p.A. (Italy)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Luminex Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Molecular Information Systems Sale, by Type, Application, Technology, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Molecular Information Systems (Value)
      • 7.2.1. Global Molecular Information Systems by: Type (Value)
        • 7.2.1.1. Reagents & Kits
        • 7.2.1.2. Software & Service
        • 7.2.1.3. Instruments [Table-top Instruments, Portable & PoC Instruments]
      • 7.2.2. Global Molecular Information Systems by: Application (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. Infectious Disease [COVID-19, Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other]
        • 7.2.2.3. Genetic Tests
        • 7.2.2.4. Oncology Testing [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other]
        • 7.2.2.5. Others
      • 7.2.3. Global Molecular Information Systems by: Technology (Value)
        • 7.2.3.1. Polymerase Chain Reaction (PCR)
        • 7.2.3.2. DNA Sequencing & NSS
        • 7.2.3.3. DNA Microarrays
        • 7.2.3.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        • 7.2.3.5. Others
      • 7.2.4. Global Molecular Information Systems by: End User (Value)
        • 7.2.4.1. Hospital & Academic Laboratories
        • 7.2.4.2. Clinics
        • 7.2.4.3. Diagnostic Laboratories
        • 7.2.4.4. Others
      • 7.2.5. Global Molecular Information Systems Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Molecular Information Systems (Price)
      • 7.3.1. Global Molecular Information Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Information Systems: by Type(USD Million)
  • Table 2. Molecular Information Systems Reagents & Kits , by Region USD Million (2015-2020)
  • Table 3. Molecular Information Systems Software & Service , by Region USD Million (2015-2020)
  • Table 4. Molecular Information Systems Instruments [Table-top Instruments, Portable & PoC Instruments] , by Region USD Million (2015-2020)
  • Table 5. Molecular Information Systems: by Application(USD Million)
  • Table 6. Molecular Information Systems Oncology , by Region USD Million (2015-2020)
  • Table 7. Molecular Information Systems Infectious Disease [COVID-19, Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other] , by Region USD Million (2015-2020)
  • Table 8. Molecular Information Systems Genetic Tests , by Region USD Million (2015-2020)
  • Table 9. Molecular Information Systems Oncology Testing [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other] , by Region USD Million (2015-2020)
  • Table 10. Molecular Information Systems Others , by Region USD Million (2015-2020)
  • Table 11. Molecular Information Systems: by Technology(USD Million)
  • Table 12. Molecular Information Systems Polymerase Chain Reaction (PCR) , by Region USD Million (2015-2020)
  • Table 13. Molecular Information Systems DNA Sequencing & NSS , by Region USD Million (2015-2020)
  • Table 14. Molecular Information Systems DNA Microarrays , by Region USD Million (2015-2020)
  • Table 15. Molecular Information Systems Isothermal Nucleic Acid Amplification Technology (INAAT) , by Region USD Million (2015-2020)
  • Table 16. Molecular Information Systems Others , by Region USD Million (2015-2020)
  • Table 17. Molecular Information Systems: by End User(USD Million)
  • Table 18. Molecular Information Systems Hospital & Academic Laboratories , by Region USD Million (2015-2020)
  • Table 19. Molecular Information Systems Clinics , by Region USD Million (2015-2020)
  • Table 20. Molecular Information Systems Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 21. Molecular Information Systems Others , by Region USD Million (2015-2020)
  • Table 22. South America Molecular Information Systems, by Country USD Million (2015-2020)
  • Table 23. South America Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 24. South America Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 25. South America Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 26. South America Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 27. Brazil Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 28. Brazil Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 29. Brazil Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 30. Brazil Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 31. Argentina Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 32. Argentina Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 33. Argentina Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 34. Argentina Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 35. Rest of South America Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 36. Rest of South America Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 37. Rest of South America Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 38. Rest of South America Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 39. Asia Pacific Molecular Information Systems, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 42. Asia Pacific Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 43. Asia Pacific Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 44. China Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 45. China Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 46. China Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 47. China Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 48. Japan Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 49. Japan Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 50. Japan Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 51. Japan Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 52. India Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 53. India Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 54. India Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 55. India Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 56. South Korea Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 57. South Korea Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 58. South Korea Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 59. South Korea Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 60. Taiwan Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 61. Taiwan Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 62. Taiwan Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 63. Taiwan Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 64. Australia Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 65. Australia Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 66. Australia Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 67. Australia Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 72. Europe Molecular Information Systems, by Country USD Million (2015-2020)
  • Table 73. Europe Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 74. Europe Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 75. Europe Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 76. Europe Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 77. Germany Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 78. Germany Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 79. Germany Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 80. Germany Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 81. France Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 82. France Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 83. France Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 84. France Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 85. Italy Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 86. Italy Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 87. Italy Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 88. Italy Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 89. United Kingdom Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 90. United Kingdom Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 91. United Kingdom Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 92. United Kingdom Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 93. Netherlands Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 94. Netherlands Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 95. Netherlands Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 96. Netherlands Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 97. Rest of Europe Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 98. Rest of Europe Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 99. Rest of Europe Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 100. Rest of Europe Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 101. MEA Molecular Information Systems, by Country USD Million (2015-2020)
  • Table 102. MEA Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 103. MEA Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 104. MEA Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 105. MEA Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 106. Middle East Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 107. Middle East Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 108. Middle East Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 109. Middle East Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 110. Africa Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 111. Africa Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 112. Africa Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 113. Africa Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 114. North America Molecular Information Systems, by Country USD Million (2015-2020)
  • Table 115. North America Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 116. North America Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 117. North America Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 118. North America Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 119. United States Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 120. United States Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 121. United States Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 122. United States Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 123. Canada Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 124. Canada Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 125. Canada Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 126. Canada Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 127. Mexico Molecular Information Systems, by Type USD Million (2015-2020)
  • Table 128. Mexico Molecular Information Systems, by Application USD Million (2015-2020)
  • Table 129. Mexico Molecular Information Systems, by Technology USD Million (2015-2020)
  • Table 130. Mexico Molecular Information Systems, by End User USD Million (2015-2020)
  • Table 131. Molecular Information Systems: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Molecular Information Systems: by Type(USD Million)
  • Table 145. Molecular Information Systems Reagents & Kits , by Region USD Million (2021-2026)
  • Table 146. Molecular Information Systems Software & Service , by Region USD Million (2021-2026)
  • Table 147. Molecular Information Systems Instruments [Table-top Instruments, Portable & PoC Instruments] , by Region USD Million (2021-2026)
  • Table 148. Molecular Information Systems: by Application(USD Million)
  • Table 149. Molecular Information Systems Oncology , by Region USD Million (2021-2026)
  • Table 150. Molecular Information Systems Infectious Disease [COVID-19, Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other] , by Region USD Million (2021-2026)
  • Table 151. Molecular Information Systems Genetic Tests , by Region USD Million (2021-2026)
  • Table 152. Molecular Information Systems Oncology Testing [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other] , by Region USD Million (2021-2026)
  • Table 153. Molecular Information Systems Others , by Region USD Million (2021-2026)
  • Table 154. Molecular Information Systems: by Technology(USD Million)
  • Table 155. Molecular Information Systems Polymerase Chain Reaction (PCR) , by Region USD Million (2021-2026)
  • Table 156. Molecular Information Systems DNA Sequencing & NSS , by Region USD Million (2021-2026)
  • Table 157. Molecular Information Systems DNA Microarrays , by Region USD Million (2021-2026)
  • Table 158. Molecular Information Systems Isothermal Nucleic Acid Amplification Technology (INAAT) , by Region USD Million (2021-2026)
  • Table 159. Molecular Information Systems Others , by Region USD Million (2021-2026)
  • Table 160. Molecular Information Systems: by End User(USD Million)
  • Table 161. Molecular Information Systems Hospital & Academic Laboratories , by Region USD Million (2021-2026)
  • Table 162. Molecular Information Systems Clinics , by Region USD Million (2021-2026)
  • Table 163. Molecular Information Systems Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 164. Molecular Information Systems Others , by Region USD Million (2021-2026)
  • Table 165. South America Molecular Information Systems, by Country USD Million (2021-2026)
  • Table 166. South America Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 167. South America Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 168. South America Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 169. South America Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 170. Brazil Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 171. Brazil Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 172. Brazil Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 173. Brazil Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 174. Argentina Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 175. Argentina Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 176. Argentina Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 177. Argentina Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 178. Rest of South America Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 179. Rest of South America Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 180. Rest of South America Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 181. Rest of South America Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 182. Asia Pacific Molecular Information Systems, by Country USD Million (2021-2026)
  • Table 183. Asia Pacific Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 184. Asia Pacific Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 185. Asia Pacific Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 186. Asia Pacific Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 187. China Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 188. China Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 189. China Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 190. China Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 191. Japan Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 192. Japan Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 193. Japan Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 194. Japan Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 195. India Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 196. India Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 197. India Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 198. India Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 199. South Korea Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 200. South Korea Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 201. South Korea Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 202. South Korea Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 203. Taiwan Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 204. Taiwan Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 205. Taiwan Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 206. Taiwan Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 207. Australia Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 208. Australia Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 209. Australia Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 210. Australia Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 215. Europe Molecular Information Systems, by Country USD Million (2021-2026)
  • Table 216. Europe Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 217. Europe Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 218. Europe Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 219. Europe Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 220. Germany Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 221. Germany Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 222. Germany Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 223. Germany Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 224. France Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 225. France Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 226. France Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 227. France Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 228. Italy Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 229. Italy Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 230. Italy Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 231. Italy Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 232. United Kingdom Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 233. United Kingdom Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 234. United Kingdom Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 235. United Kingdom Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 236. Netherlands Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 237. Netherlands Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 238. Netherlands Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 239. Netherlands Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 240. Rest of Europe Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 241. Rest of Europe Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 242. Rest of Europe Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 243. Rest of Europe Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 244. MEA Molecular Information Systems, by Country USD Million (2021-2026)
  • Table 245. MEA Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 246. MEA Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 247. MEA Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 248. MEA Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 249. Middle East Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 250. Middle East Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 251. Middle East Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 252. Middle East Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 253. Africa Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 254. Africa Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 255. Africa Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 256. Africa Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 257. North America Molecular Information Systems, by Country USD Million (2021-2026)
  • Table 258. North America Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 259. North America Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 260. North America Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 261. North America Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 262. United States Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 263. United States Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 264. United States Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 265. United States Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 266. Canada Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 267. Canada Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 268. Canada Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 269. Canada Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 270. Mexico Molecular Information Systems, by Type USD Million (2021-2026)
  • Table 271. Mexico Molecular Information Systems, by Application USD Million (2021-2026)
  • Table 272. Mexico Molecular Information Systems, by Technology USD Million (2021-2026)
  • Table 273. Mexico Molecular Information Systems, by End User USD Million (2021-2026)
  • Table 274. Molecular Information Systems: by Type(USD/Units)
  • Table 275. Research Programs/Design for This Report
  • Table 276. Key Data Information from Secondary Sources
  • Table 277. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Information Systems: by Type USD Million (2015-2020)
  • Figure 5. Global Molecular Information Systems: by Application USD Million (2015-2020)
  • Figure 6. Global Molecular Information Systems: by Technology USD Million (2015-2020)
  • Figure 7. Global Molecular Information Systems: by End User USD Million (2015-2020)
  • Figure 8. South America Molecular Information Systems Share (%), by Country
  • Figure 9. Asia Pacific Molecular Information Systems Share (%), by Country
  • Figure 10. Europe Molecular Information Systems Share (%), by Country
  • Figure 11. MEA Molecular Information Systems Share (%), by Country
  • Figure 12. North America Molecular Information Systems Share (%), by Country
  • Figure 13. Global Molecular Information Systems: by Type USD/Units (2015-2020)
  • Figure 14. Global Molecular Information Systems share by Players 2020 (%)
  • Figure 15. Global Molecular Information Systems share by Players (Top 3) 2020(%)
  • Figure 16. Global Molecular Information Systems share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 20. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Agilent Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Biomerieux SA (France) Revenue, Net Income and Gross profit
  • Figure 23. Biomerieux SA (France) Revenue: by Geography 2020
  • Figure 24. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 25. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 26. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 28. F.Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. F.Hoffmann-La Roche (Switzerland) Revenue: by Geography 2020
  • Figure 30. Hologic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Hologic Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Siemens Healthineers AG (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Siemens Healthineers AG (Germany) Revenue: by Geography 2020
  • Figure 34. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 35. QIAGEN N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 36. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 38. DiaSorin S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 39. DiaSorin S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 40. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 41. Luminex Corporation (United States) Revenue: by Geography 2020
  • Figure 42. Global Molecular Information Systems: by Type USD Million (2021-2026)
  • Figure 43. Global Molecular Information Systems: by Application USD Million (2021-2026)
  • Figure 44. Global Molecular Information Systems: by Technology USD Million (2021-2026)
  • Figure 45. Global Molecular Information Systems: by End User USD Million (2021-2026)
  • Figure 46. South America Molecular Information Systems Share (%), by Country
  • Figure 47. Asia Pacific Molecular Information Systems Share (%), by Country
  • Figure 48. Europe Molecular Information Systems Share (%), by Country
  • Figure 49. MEA Molecular Information Systems Share (%), by Country
  • Figure 50. North America Molecular Information Systems Share (%), by Country
  • Figure 51. Global Molecular Information Systems: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Agilent Technologies Inc. (United States)
  • Biomerieux SA (France)
  • Becton, Dickinson, and Company (United States)
  • Danaher Corporation (United States)
  • F.Hoffmann-La Roche (Switzerland)
  • Hologic Inc. (United States)
  • Siemens Healthineers AG (Germany)
  • QIAGEN N.V. (Netherlands)
  • Thermo Fisher Scientific, Inc. (United States)
  • DiaSorin S.p.A. (Italy)
  • Luminex Corporation (United States)
Additional players considered in the study are as follows:
Molbio Diagnostics Pvt. Ltd. (India) , geneOmbio Technologies Pvt. Ltd. (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation